Uptake and toxicity of copper oxide nanoparticles in C6 glioma cells

Joshi, Arundhati, Rastedt, Wiebke, Faber, Kathrin, Schultz, Aaron G., Bulcke, Felix and Dringen, Ralf 2016, Uptake and toxicity of copper oxide nanoparticles in C6 glioma cells, Neurochemical research, vol. 41, no. 11, pp. 3004-3019, doi: 10.1007/s11064-016-2020-z.

Attached Files
Name Description MIMEType Size Downloads

Title Uptake and toxicity of copper oxide nanoparticles in C6 glioma cells
Author(s) Joshi, Arundhati
Rastedt, Wiebke
Faber, Kathrin
Schultz, Aaron G.ORCID iD for Schultz, Aaron G. orcid.org/0000-0002-7333-7646
Bulcke, Felix
Dringen, Ralf
Journal name Neurochemical research
Volume number 41
Issue number 11
Start page 3004
End page 3019
Total pages 16
Publisher Springer
Place of publication Berlin, Germany
Publication date 2016-11
ISSN 0364-3190
1573-6903
Keyword(s) nanoparticles
copper
glioma
toxicity
biocompatability
Biocompatibility
Summary Copper oxide nanoparticles (CuO-NPs) are frequently used for many technical applications, but are also known for their cell toxic potential. In order to investigate a potential use of CuO-NPs as a therapeutic drug for glioma treatment, we have investigated the consequences of an application of CuO-NPs on the cellular copper content and cell viability of C6 glioma cells. CuO-NPs were synthesized by a wet-chemical method and were coated with dimercaptosuccinic acid and bovine serum albumin to improve colloidal stability in physiological media. Application of these protein-coated nanoparticles (pCuO-NPs) to C6 cells caused a strong time-, concentration- and temperature-dependent copper accumulation and severe cell death. The observed loss in cellular MTT-reduction capacity, the loss in cellular LDH activity and the increase in the number of propidium iodide-positive cells correlated well with the specific cellular copper content. C6 glioma cells were less vulnerable to pCuO-NPs compared to primary astrocytes and toxicity of pCuO-NPs to C6 cells was only observed for incubation conditions that increased specific cellular copper contents above 20 nmol copper per mg protein. Both cellular copper accumulation as well as the pCuO-NP-induced toxicity in C6 cells were prevented by application of copper chelators, but not by endocytosis inhibitors, suggesting that liberation of copper ions from the pCuO-NPs is the first step leading to the observed toxicity of pCuO-NP-treated glioma cells.
Language eng
DOI 10.1007/s11064-016-2020-z
Field of Research 030302 Nanochemistry and Supramolecular Chemistry
119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970103 Expanding Knowledge in the Chemical Sciences
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Springer
Persistent URL http://hdl.handle.net/10536/DRO/DU:30087793

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 13 times in TR Web of Science
Scopus Citation Count Cited 12 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 260 Abstract Views, 3 File Downloads  -  Detailed Statistics
Created: Thu, 10 Nov 2016, 12:52:04 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.